Exam Set Questions And Revised
Correct Answers | Passed!!
Climacteric phase - ANSWER : The period of endrocrinologic,
somatic, and transitory psychologic changes that occur around
the time of menopause.
Early menopause - ANSWER : LMP before age 45
Late menopause - ANSWER : LMP after age 54
Primary ovarian insufficiency - ANSWER : Menopause that
occurs before age 40
Early menopause transition (stage -2) - ANSWER : Persistent
difference of 7 days or more in the length of consecutive cycles.
Late menopause transition (stage -1) - ANSWER : 60 or more
consecutive days of amenorrhea
, Luteal out of phase event (LOOP) - ANSWER : Explains why
some perimenopausal women have elevated estrogen level
sometimes...In the early menopause transition, elevated FSH
levels are adequate to recruit a second follicle which results in a
follicular phase-like rise in estradiol secretion superimposed on
the mid-to-late luteal phase of the ongoing ovulatory cycle.
Obese women and estradiol levels during menopause -
ANSWER : Obese women are more likely to have anovulatory
cycles with high estradiol levels. They are also more likely to
have lower premenopause yet higher postmenopause estradiol
levels compared with women of normal weight. (why they are
at higher risk of endometrial cancer)
Chinese and Japanese women - ANSWER : These ethnic groups
have lower estradiol levels then white, black and hispanic
women.
stage +2 - ANSWER : late menopause stage: 5-8 years after
FMP. Somatic aging predominates. Increased genitourinary
symptoms.
, Stages +1a, +1b, +1c - ANSWER : early post menopause: 2
years after FMP. FSH rises, estradiol decreases. VMS
predominate.
Elevated FSH, LH - ANSWER : Endocrine labs after menopause
AMH, inhibin B - ANSWER : These hormones work during
reproductive years to not deplete follicle pool too quickly.
Phases during menopause transition and PMS symptoms -
ANSWER : Menstrual cycle variable, persistent >7 day
difference between difference in length of consecutive cycles.
How to respond if a patient requests FSH lab? - ANSWER :
many pitfalls, variable depending on the day of the cycle you
draw the lab, normal or low FSH is not helpful.
The potentially superior marker of menopause, a lab. -
ANSWER : AMH
DHEA (dehydroepiandrosterone) - ANSWER : Adrenal
androgens: precursor hromones produced by the adrenal gland
, that are enzymatically converted to active androgens or
estrogens in peripheral tissues.
Location of estrogen receptors - ANSWER : Vagina, vulva,
urethra, trigone of the bladder
Effects of estrogen on tissue - ANSWER : maintain blood flow,
the collagen, and HA within the epithelial surfaces. Supports
microbiome which supports acidity of vagina and protects
tissue from pathogens.
Vaginal changes with menopause - ANSWER : Thinning, loss of
elasticity, loss or absence or rugae.
Vagina and urethra in menopause - ANSWER : vagina narrows,
urethra moves closer to the introitus.
Stress urinary incontinence - ANSWER : Vaginal estrogen and
urinary incontinence: what type does it help with?
Treatment for FPHL - ANSWER : Minoxidil, spironolactone,
finasteride, estrogen therapy